Biomedical, Clinical & Life Sciences

Request Ticket // Limit: 3* // Tickets Available: 2

The University of Arizona may submit a total of three nominations:

• One from the College of Medicine - Tucson // Tickets Available: 0
  Y. Shirai (Family and Community Medicine)
• One from the College of Medicine - Phoenix // Tickets Available: 1
• One from the College of Nursing // Tickets Available: 1

Eligibility:

1. Be a benefits-eligible faculty member in a United States accredited nursing school, allopathic medical school, or osteopathic medical school. Candidates should have approximately three to eight years of faculty experience at the time of application.
2. Be a doctorally prepared faculty member in good standing at the sponsoring school.
3. Be nominated by the dean of the nursing or medical school. There can be only one nominee per nursing or medical school, and a nursing or medical school with a first-year Macy Faculty Scholar is precluded from nominating a candidate.
4. Have an educational scholarship project with the appropriate institutional support.
5. Have a faculty mentor who will advise the candidate on the candidate's educational project and career development.
6. Have an institutional commitment for the protection of 50% of the candidate’s time.
7. Be a citizen or permanent resident of the United States or its territories.

Program Overview

The Macy Faculty Scholars Program, now in its second decade, aims to identify and nurture promising early-career educators in medicine and nursing. The program will help develop the next generation of national leaders in medical and nursing education by identifying outstanding educators, physicians, nurses, and role models—individuals who represent the breadth of diversity seen in learners, patient populations, and health care settings around the country. By providing the Scholars with resources—especially protected time, mentorship, and a professional network of colleagues—the program aims to accelerate Scholars’ careers, to turn their teaching practice into scholarship, and to help them become impactful leaders locally, nationally, and beyond.

This is a career development award. The Foundation is interested in candidates for whom the program will have the maximum impact at this point in their career and who also have the greatest possibility for future impact at their home institutions and beyond. Macy Faculty Scholars will participate in the Macy Faculty Scholars Annual Meeting and will be part of the family of Macy Faculty Scholars for the remainder of their careers.

In order to develop the careers of educators who are future leaders, the Macy Faculty Scholars Program will provide salary support for each Scholar up to $100,000 per year, which will protect 50% of the Scholar’s time over two years. The Scholar will devote this time to a mentored educational scholarly project and other appropriate career development activities.

Limit: 1 LOI per department

V. Lai (Psychology) 

Eligibility
Organizations may submit only one Letter of Inquiry and corresponding proposal per grant cycle. Common exceptions include proposals submitted by separate departments of large universities. 


RRF funds research that seeks to identify interventions, policies and practices to improve the well-being of older adults and/or their caregivers. Preference is given to projects aimed at generating practical knowledge and guidance that can be used by advocates, policy-makers, providers, and the aging network. Of particular interest are:

• Interventional trials; translational studies; and health services and policy research
• Projects that build on the investigator’s past studies
• Proposals that include robust dissemination plans, if appropriate, to assure that findings reach audiences positioned to act on them

Limit: 2* // Tickets Available: 0

Basic through Pre-clinical Research Studies // Limit: 1 // Tickets Available: 0
S. Soto (Public Health)

Clinical through Public Health Research // Limit: 1 // Tickets Available: 0
E. Lee (Engineering)

ADA will accept up to two (2) nominations per institution with one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research.

Nominations are welcomed from all areas of diabetes and span prevention, management, and cure of all diabetes types (i.e. type 1, type 2 and gestational), diabetes-related disease states (obesity, prediabetes, and other insulin resistant states) and complications. The program intends to attract a broad range of expertise to the field of diabetes from various fields of science and technology, including medicine, biology, chemistry, engineering, mathematics, and physics.

Examples of basic through preclinical research studies (for nomination #1) include:

• Innovative mechanistic studies on fundamental or new aspects of biology
• Novel insights derived from data science using AI/Machine Learning
• Development of new technologies, devices, and/or experimental approaches
• Identification and validation of novel and unique therapeutic targets 

Examples of clinical through public health research (for nomination #2) include:

• Clinical experimental medicine studies
• Identification and validation of novel biomarkers
• Health services research
• Behavioral research
• Population epidemiology
• Health economics research
• Patient preference / Quality of Life
• Dissemination and implementation science

• Health Care system-based interventions

   

Initiator Award Eligibility

• Applicants must currently be in research training positions (i.e. post-doctoral fellowships, research fellowships) and can have no more than seven (7) years of training since their doctoral degree.
• Initiator award recipients cannot concurrently hold an NIH K99/R00 grant. All other Career Development awards are allowable (unless holding of concurrent awards is prohibited by the other granting agency).
• Candidate’s must hold a full-time appointment at their sponsoring institution. Rare exceptions to full- time positions may be granted on a case-by-case basis and must be pre-approved by ADA Research Programs staff prior to application submission.
• Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree.
• Applicant fellowship positions must be at university-affiliated institutions or other non-profit research institutions within the United States and U.S. possessions.
• To assure continued excellence and diversity among applicants and awardees, the Association welcomes applications from all qualified individuals and strongly encourages applications from persons with diverse backgrounds, including minority groups that are underrepresented in biomedical research.
• Individuals must have permission to work within the U.S., either as U.S. citizens or permanent residents, or with appropriate work visas/permits. Institutional confirmation of permission to work within the U.S. will be required at the time of application submission

Limit: 1 // Tickets Available: 0

T. Moukabary (Sarver Heart Center)

Program Overview:
The Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research supports research in the area of the prevention of coronary heart disease or circulatory failure and improving care for these patients. The Program focuses on basic and translational scientific research. Clinical studies are currently ineligible.

Action Applications examining the intersection of coronary heart disease and/or congestive heart failure and COVID-19 or similar viral illnesses are highly encouraged to apply.

Eligibility:
In accordance with Mr. Geneen’s directives, the Program supports smaller, mid-sized institutions. Each invited institution may only submit one application from a full-time faculty member. Junior faculty and those with less than $500,000 in direct costs funding at the time of application, are encouraged to apply. United States citizenship is not required.

No Applicants // Limit: 1 // Tickets Available: 1 

The University of Arizona Cancer Center (UACC) can nominate one applicant for the Susan G. Komen Rising Star Researcher Award 2025 which recognizes innovative work, budding leadership and dedicated mentorship in breast cancer research and treatment.

For more information please contact: UACC-PreAward.

Purpose of Award:

This award will honor an investigator whose work has the potential to significantly impact the breast cancer field, who demonstrates strong leadership potential in the breast cancer community and who exhibits a strong commitment to trainee mentorship.

The Rising Star Researcher Award has become another marquee breast cancer research award for Susan G. Komen and complements the Brinker Awards established in 1992 to honor pioneers and distinguished investigators in basic science and clinical research.

The Rising Star Researcher Award will be given annually to:

• a breast cancer researcher from across the continuum of basic, translational, clinical, population health and implementation science research
• who is driving science that is having a substantial impact, expanding our understanding of breast cancer and/or improving breast cancer care and outcomes,
• is beginning to establish visibility and leadership in the field, beyond their scientific and/or clinical discoveries, and
• is demonstrating mentorship that is significantly impacting the education and professional development of research and/or clinical trainees.

No Applicants // Limit: 3* // Tickets Available: 3

*The University of Arizona Cancer Center (UACC) can nominate up to three applicants (one per category) for the Susan G. Komen’s Brinker Awards for Scientific Distinction 2025 which recognizes pioneering work in breast cancer research and treatment. 

For more information please contact: UACC-PreAward.

Award Categories (Limit 1 Each) 

• The Brinker Award for Scientific Distinction in Basic Science will be presented to a basic science and/or translational researcher whose scientific discoveries or novel technologies have substantively impacted our understanding of the basic biology and intrinsic molecular processes driving breast cancer to improve breast cancer care.
• The Brinker Award for Scientific Distinction in Clinical Research will be presented to a clinical researcher who has advanced new approaches for prevention, detection, diagnosis and treatment that have paved the way for new clinical and therapeutic applications and/or practice changing, patient-focused care for breast cancer.
• The Brinker Award for Scientific Distinction in Population Science will be presented to a researcher who has made pivotal advances in implementing science, cancer care delivery, health services research, epidemiology and/or developed innovative evidence-based interventions to enhance breast cancer outcomes.

Limit: 2* // Tickets Available: 1

K. Huntoon (Neurosurgery)- V Scholar

The University of Arizona Cancer Center (UACC) can nominate can nominate up to two proposals: one Translational OR V Scholar nominee and one All-Star nominee (if eligible) for the V Foundation Pediatric Cancer Research Grant 2025.

For more information please contact: UACC-PreAward.

Eligibility

Nominee must meet all of the following criteria by the nomination due date:

• Nominated by their Cancer Center Director or similar high ranking research official.
• Employed at a non-profit research institution (e.g., 501c3, Section 170).
• Either a US Citizen or a permanent legal resident in the US
• See additional criteria for each mechanism listed in corresponding RFA within the Supporting Documents section above.

Limit: 1 // Tickets Available: 0

J. Streicher (Pharmacology)

Objective
The program's objective is to support projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. It is expected that investigations supported by these grants will yield high-impact findings and result in major grant applications and funding as well as significant publications in high-impact journals.

Eligibility
The nominated candidate must be a full-time associate professor or full professor at a US academic institution working in the area of studies of brain function in health and disease. Current major NIH or other peer-reviewed funding is preferred but evidence of such funding in the past three years is essential. Studies should be related to either normal human brain development or specifically identified disease states. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease. The grant proposal must detail a new research project that is not funded by other sources. This grant is not to be used as bridge funding. 

Investigators at institutions that are affiliated with a medical school or university are eligible to apply only through the institution where they hold a full-time faculty position. 

Scientists that have previously received a BRF Scientific Innovations Award may not receive the award for a second time until five years has elapsed since the beginning date of the prior award. Grant requirements from all previous awards must be met.  Only one PI may apply per application. (Applicant may include the name of a Co-PI within or from another institution, but no additional supporting materials for the Co-PI are required, including biosketch, current grants, abstracts, etc.) 

No Applicants // Limit: 4* (see below) // Tickets Available: 4

Cancer Data Science // Limit: 1 // Tickets Available: 1

Cancer Control Science // Limit: 1 // Tickets Available: 1

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Number of Applications
Applicant organizations may submit more than one application, provided that each application is scientifically distinct, and each is from a different candidate.

No Applicants // Limit: 1 // Tickets Available: 1

Application Limits:
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.

Purpose:
The purpose of this program is to reduce financial disincentives to living organ donation by providing means-tested reimbursement of lost wages, transportation, meals, and dependent care (child care and elder care) expenses and other qualified expenses to living organ donors.